Delivery Order SPE2DR25D1202-SPE2DR26F72AC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Aponvie 32 mg/4.4 mL vials with a ceiling value of $2,470.69 under a firm fixed price contract. This delivery order represents a non-set-aside, competitively awarded procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $13,881.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Aponvie 32 mg/4.4 ml vials. The contract, which represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), was competitively awarded with no set-aside designation. Performance will be conducted at the contractor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $5,835.04 for APONVIE 32 mg/4.4 ml vials. The contract utilizes firm fixed pricing, was competitively awarded with no set-aside designation, and is scheduled for completion by September 19, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of APONVIE 32 mg/4.4 ml vials. The award, valued at $1,138.38, has a completion date of February 21, 2024. This delivery order is a task order issued under Amerisourcebergen Drug Corp's single award indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.20 firm fixed-price delivery order is for the supply of APONVIE 32 MG/4.4 ML VIAL 4.4ML, a pharmaceutical product. The contract has an ultimate completion date of June 27, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $15,033.30 delivery order (Contract 4569946721) to AmerisourceBergen Drug Corp on November 7, 2025, with completion scheduled for November 10, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award based on the vendor's demonstrated capabilities. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform all work at its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order valued at $14,865.12 by the Defense Logistics Agency's Medical Supply Chain on November 1, 2025. This non-set-aside competitive award is scheduled for completion by November 3, 2025, and represents a child order under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $30,968.20 to AmerisourceBergen Drug Corp on November 4, 2025, with an ultimate completion date of November 26, 2025. This non-set-aside contract, issued under the Pharmaceutical Prime Vendor (PV) Division, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will...
- The Defense Logistics Agency awarded a delivery order valued at $2,202.50 to AmerisourceBergen Drug Corp on November 4, 2025, under the Pharmaceutical Prime Vendor Global Program. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. This delivery order represents a non-competitive award under an existing firm fixed-price contract vehicle, consistent...
- The Defense Logistics Agency's Medical Supply Chain awarded a $58,117.57 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72ACDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,060.20 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Aponvie 32 mg/4.4 mL vials. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of November 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC functions as a comprehensive global pharmaceutical support vehicle enabling supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Aponvie reflects the company's ongoing role in supporting military medical supply chain requirements through the DLA Troop Support Medical contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/7/25 |